GI Manifestation in Scleroderma
The gastrointestinal (GI) system frequently experiences complications in systemic sclerosis. Pathological changes in the GI system can be revealed from the early onset of the disease, such as esophageal hypomotility, to the late stage of the disease, where severe complications like intestinal pseudo...
Saved in:
| Main Author: | Chingching Foocharoen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
World Scientific Publishing
2024-01-01
|
| Series: | Journal of Clinical Rheumatology and Immunology |
| Online Access: | https://www.worldscientific.com/doi/10.1142/S2661341724740183 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cytokines as Therapeutic Targets for the Gastrointestinal Manifestations of Scleroderma
by: Jennifer M Raoul, et al.
Published: (2004-01-01) -
Clinical course and potential associated factors of progressive calcinosis cutis in early systemic sclerosis: a cohort study
by: Vassana Kanjanajarurat, et al.
Published: (2025-12-01) -
Mimics of scleroderma
by: Kaveri K Nalianda, et al.
Published: (2017-01-01) -
The pathogenesis of scleroderma
by: Latika Gupta, et al.
Published: (2017-01-01) -
Multiple small bowel GIST as GI manifestation of neurofibromatosis type I: A case report
by: Habtamu Tsegaye, et al.
Published: (2025-03-01)